HPV positivity in HIV+ women: 1 in 5 screened at Gujarat's GCRI tests positive

Share:
Audio Loading voice…
HPV positivity in HIV+ women: 1 in 5 screened at Gujarat's GCRI tests positive

Synopsis

A quiet but potentially transformative public health finding has emerged from Ahmedabad: nearly 1 in 5 HIV-positive women screened at GCRI tested HPV-positive — more than four times Gujarat's general population rate. With 94 precancerous cases and one early-stage cancer caught early, this integrated HIV-cancer screening model is now eyeing statewide expansion after winning a national healthcare excellence award.

Key Takeaways

1,542 HIV-positive women screened at GCRI's ART Centre , Ahmedabad, since March 2025 .
319 women (20.69%) tested positive for HPV — over four times Gujarat's general population rate of roughly 5% .
94 cases of cervical intraepithelial neoplasia (CIN) detected, including 1 case of CIN 3 and 1 case of early-stage cervical cancer .
The initiative has won the FICCI Healthcare Excellence Award 2026 for patient care and service delivery.
GCRI plans to expand the integrated screening model to other ART centres across Gujarat, subject to resource availability.

Nearly one in five women living with HIV who underwent cervical cancer screening at the Gujarat Cancer Research Institute (GCRI) in Ahmedabad have tested positive for the human papillomavirus (HPV), according to data from an ongoing integrated screening initiative. The programme also detected one case of early-stage cervical cancer, underscoring the critical need for targeted oncological screening among immunocompromised women.

Key Findings from the Screening Data

Since the initiative was launched in March 2025, GCRI has screened 1,542 HIV-positive women using HPV DNA testing at the Antiretroviral Therapy (ART) Centre at Ahmedabad's Civil Hospital. Of those screened, 319 women — or 20.69% — returned a positive HPV result, while 1,223 tested negative.

This positivity rate is markedly higher than those recorded among Gujarat's general population — 4.82% in urban areas and 5.22% in rural areas — highlighting the disproportionate vulnerability of women living with HIV to persistent high-risk HPV infections, which significantly elevate the risk of cervical cancer development.

Colposcopy Results and Cancer Detection

Following initial HPV screening, 150 women were referred for colposcopy — a more detailed examination of the cervix. The investigations identified 94 cases of cervical intraepithelial neoplasia (CIN), a condition involving precancerous abnormal cell changes in cervical tissue.

The breakdown included 63 cases of CIN 1, 30 cases of CIN 2, and one case of CIN 3. One additional case of early-stage cervical cancer was detected, enabling timely medical intervention that may prove lifesaving. Notably, CIN 2 and CIN 3 represent more advanced precancerous changes that require close monitoring and treatment to prevent progression.

Why This Integration Matters

The programme was designed to embed cervical cancer detection into routine HIV care — a model that health experts have long advocated for, given that women living with HIV face a significantly higher burden of persistent high-risk HPV infections. Without targeted screening, precancerous lesions in this population frequently go undetected until they reach advanced, harder-to-treat stages.

This comes amid broader national efforts to reduce India's cervical cancer burden. India accounts for a substantial share of global cervical cancer deaths, and the disease disproportionately affects women in lower-income groups who have limited access to regular gynaecological care.

Award Recognition and Expansion Plans

The initiative has been recognised with the FICCI Healthcare Excellence Award 2026 in the 'Excellence in Patient Care and Service Delivery' category, acknowledging its model of integrating cancer prevention and early diagnosis into routine HIV treatment services.

GCRI, which is jointly managed by the Gujarat state government and the Gujarat Cancer Society, plans to extend the integrated screening model to other ART centres across the state, subject to practical feasibility and resource availability. The programme is being implemented in alignment with the state's broader preventive healthcare agenda and efforts to improve early diagnosis access.

As the model matures, its replication across other states with significant HIV-positive populations could meaningfully shift outcomes for a group that has historically fallen through the gaps between infectious disease care and cancer prevention services.

Point of View

Yet routine integrated screening has remained the exception rather than the norm. GCRI's model demonstrates proof of concept, but the real question is whether Gujarat's expansion plans will secure consistent funding and trained personnel beyond pilot-scale enthusiasm. With India carrying one of the world's heaviest cervical cancer burdens, a scalable ART-linked screening protocol could save thousands of lives annually — if it moves from award-winning initiative to standard of care.
NationPress
17 Nov 2026

Frequently Asked Questions

What did the GCRI HPV screening of HIV-positive women find?
The Gujarat Cancer Research Institute (GCRI) found that 319 out of 1,542 HIV-positive women screened — or 20.69% — tested positive for HPV. The screening also detected 94 precancerous cervical lesions and one case of early-stage cervical cancer, allowing timely treatment.
Why are HIV-positive women at higher risk for HPV and cervical cancer?
Women living with HIV have weakened immune systems, making them more susceptible to persistent high-risk HPV infections. These persistent infections significantly increase the likelihood of developing precancerous cervical lesions and cervical cancer compared to the general population.
How does the HPV positivity rate among HIV-positive women compare to the general population in Gujarat?
The HPV positivity rate of 20.69% among HIV-positive women screened at GCRI is considerably higher than the rates recorded in Gujarat's general population — 4.82% in urban areas and 5.22% in rural areas — indicating more than a fourfold difference.
What is cervical intraepithelial neoplasia (CIN) and why does it matter?
Cervical intraepithelial neoplasia (CIN) refers to abnormal, precancerous changes in cervical cells. It is classified into CIN 1, 2, and 3, with higher grades indicating greater risk of progression to cervical cancer if left untreated. Early detection through screening enables timely intervention before cancer develops.
Will this screening programme be expanded beyond Ahmedabad?
GCRI, jointly managed by the Gujarat state government and the Gujarat Cancer Society, plans to extend the integrated HIV-cervical cancer screening model to other ART centres across Gujarat, subject to practical feasibility and resource availability. No specific timeline has been announced yet.
Nation Press
The Trail

Connected Dots

Tracing the thread behind this story — newest first.

8 Dots
  1. Latest 3 months ago
  2. 3 months ago
  3. 6 months ago
  4. 8 months ago
  5. 8 months ago
  6. 9 months ago
  7. 10 months ago
  8. 1 year ago
Google Prefer NP
On Google